PD
CAI

Point72 (DIFC)’s Caris Life Sciences CAI Stock Holding History

Point72 (DIFC)’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$19.8M Buy
654,792
+600,650
+1,109% +$19.2M 1.3% 18
2025
Q2 		$1.45M Buy
+54,142
New +$1.46M 0.05% 350

Other funds holding CAI

SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Point72 (DIFC)'s CAI Position: Q3 2025 in Review

Point72 (DIFC) increased its Caris Life Sciences (CAI) stake by 1,109% in Q3 2025, buying an estimated $19.2M and bringing the position to 654,792 shares worth $19.8M. The position accounts for 1.3% of the portfolio, ranked #18.

Point72 (DIFC) first reported a position in CAI in Q2 2025 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold CAI as of Q3 2025.

  • Point72 (DIFC) held 654,792 shares of Caris Life Sciences worth $19.8M as of Q3 2025.
  • Point72 (DIFC) bought 600,650 Caris Life Sciences shares in Q3 2025, an estimated $19.2M.
  • Caris Life Sciences made up 1.3% of Point72 (DIFC)'s portfolio in Q3 2025, its #18 holding.
  • Point72 (DIFC) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.